Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Surgery|January 1, 1991
Surgical treatment of thyroid cancerF Badellino, G Margarino, M Scala, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 1998
Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancerG Canavese, A Catturich, C Vecchio, et al.
International Surgery|April 1, 1989
Retroperitoneal infectious myositisF Badellino, G Canavese, G Amoretti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 23, 2005
The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastasesM Gipponi, G Canavese, R Lionetto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1997
Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trialG Canavese, A Catturich, C Vecchio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancerL Del Mastro, O Garrone, M R Sertoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trialG Canavese, A Catturich, C Vecchio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2010
Intra-operative evaluation of the sentinel lymph node for T1-N0 breast-cancer patients: always or never? A risk/benefit and cost/benefit analysisG Canavese, P Bruzzi, A Catturich, et al.
Pageof 3